Hypertension and Atrial Fibrillation treated by Rivaroxaban for the Morning and Night with synergy with calcium antagonists
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 04 Oct 2017
At a glance
- Drugs Rivaroxaban (Primary) ; Nifedipine
- Indications Atrial fibrillation
- Focus Therapeutic Use
- Acronyms HARMONY
- 02 Oct 2017 Status changed from recruiting to active, no longer recruiting.
- 03 Apr 2015 Status changed from not yet recruiting to recruiting, according to University Hospital Medical Information Network - Japan record.
- 03 Dec 2014 New trial record